USPH · US Physical Therapy
AI read · Good for USPH
The AI's read
More visits and higher payment per visit helped USPH bring in more sales. Hospital revenue rose from less than 5% to over 13% of total sales as partnerships expanded. The company kept its full-year forecast for EBITDA, a measure of operating profit, at $102 million to $106 million. Health costs were $7 million above last year, but EBITDA grew despite them. Credit-line borrowings reached $247 million to fund acquisitions and share repurchases.